关注我们：

solidot新版网站常见问题，请点击这里查看。

To keep EpiPen sales up, Mylan threatened states, sued making bogus claims

来源于:Ars Technica
When states tried to cut health costs, the infamous drug company leapt to action. 查看全文>>